NEW YORK (GenomeWeb News) – The Penn State Hershey Cancer Institute will use $3.2 million in federal funding to start a new pharmacogenomics research center that will serve as a sample repository and research center for the institute, the university said this week.

The Penn State Center for Pharmacogenetics will house the cancer institute's samples and will be a resource and research center for translational studies focused on oncology drugs and prevention approaches.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.